Abstract
Penetration of linezolid into osteo-articular tissue and fluid was studied in 10 patients undergoing primary total knee replacement. Linezolid 600 mg 12 hourly was given orally over the 48 h before operation and intravenously 1 h before induction of anaesthesia. Mean concentrations of linezolid at 90 min after the final dose, in serum, synovial fluid, synovium, muscle and cancellous bone, assayed by HPLC, were at least twice the MIC(90) for staphylococci and streptococci. The concentrations obtained indicate good penetration of this antibiotic and support its use in the management of multidrug-resistant Gram-positive bone, joint and deep-seated soft-tissue infections.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Acetamides / administration & dosage*
-
Acetamides / blood*
-
Acetamides / pharmacokinetics
-
Aged
-
Aged, 80 and over
-
Arthritis, Rheumatoid / blood
-
Arthritis, Rheumatoid / drug therapy
-
Arthritis, Rheumatoid / metabolism
-
Bone and Bones / drug effects
-
Bone and Bones / metabolism*
-
Female
-
Humans
-
Linezolid
-
Male
-
Muscles / drug effects
-
Muscles / metabolism*
-
Osteoarthritis, Knee / blood
-
Osteoarthritis, Knee / drug therapy
-
Osteoarthritis, Knee / metabolism
-
Oxazolidinones / administration & dosage*
-
Oxazolidinones / blood*
-
Oxazolidinones / pharmacokinetics
-
Synovial Fluid / drug effects
-
Synovial Fluid / metabolism*
-
Tissue Distribution
Substances
-
Acetamides
-
Oxazolidinones
-
Linezolid